​
​

Aurinia Pharmaceuticals Ownership | Who Owns Aurinia Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Aurinia Pharmaceuticals Ownership Summary

Aurinia Pharmaceuticals is owned by 38.41% institutional investors, 7.06% insiders, and 54.53% retail investors. Armistice capital is the largest institutional shareholder, holding 7.73% of AUPH shares. iShares Russell 2000 ETF is the top mutual fund, with 2.40% of its assets in Aurinia Pharmaceuticals shares.

AUPH Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAurinia Pharmaceuticals38.41%7.06%54.53%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Armistice capital11.14M7.73%$63.59M
Blackrock9.27M6.44%$52.94M
Nea management company3.97M2.76%$22.67M
State street2.88M2.00%$16.45M
Tang capital management2.78M1.93%$15.87M
Goldman sachs group2.25M1.57%$12.87M
Nuveen asset management1.80M1.25%$10.30M
Geode capital management1.76M1.22%$10.07M
Vanguard group1.54M1.07%$8.79M
Rock springs capital management lp1.18M0.82%$6.74M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nea management company3.97M1.71%$22.67M
Tang capital management2.78M1.62%$15.87M
Armistice capital11.14M0.80%$63.59M
Virtus investment advisers82.83K0.40%$472.95K
Highmark wealth management91.20K0.31%$520.73K
Ironwood investment management89.86K0.27%$513.11K
Rock springs capital management lp1.18M0.20%$6.74M
Virtus etf advisers61.56K0.17%$351.51K
Virtus fund advisers6.79K0.15%$38.76K
Sunbelt securities160.22K0.09%$914.88K

Top Buyers

HolderShares% AssetsChange
Tang capital management2.78M1.62%729.50K
Blackrock9.27M0.00%609.18K
Segall bryant & hamill553.74K0.06%553.74K
Aqr capital management202.24K0.00%202.24K
Jpmorgan chase507.03K0.00%199.10K

Top Sellers

HolderShares% AssetsChange
Armistice capital11.14M0.80%-1.12M
Schroder investment management group---997.22K
683 capital management---400.00K
Group one trading---377.32K
Morgan stanley987.88K0.00%-316.26K

New Positions

HolderShares% AssetsChangeValue
Segall bryant & hamill553.74K0.06%553.74K$3.16M
Pdt partners171.35K0.09%171.35K$978.40K
Norges bank114.05K0.00%114.05K$651.20K
Virtus investment advisers82.83K0.40%82.83K$472.95K
Corebridge financial77.24K0.00%77.24K$441.04K

Sold Out

HolderChange
Vima-25.00
Nelson, van denburg & campbell wealth management group-26.00
Walleye trading-300.00
Lowe wealth advisors-531.00
Allspring global investments-595.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024180-8.63%55,314,7510.64%382.61%8513.33%42-32.26%
Mar 31, 2024197-6.19%54,961,1773.27%382.78%75-9.64%621.64%
Dec 31, 2023210-2.78%53,221,0035.95%373.00%83-10.75%6122.00%
Sep 30, 2023216-1.37%50,234,1310.83%352.88%93-2.11%50-9.09%
Jun 30, 20232198.42%49,820,958-0.35%342.84%95-2.06%5519.57%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Russell 2000 ETF3.44M2.40%-7.73K
Fidelity Small Cap Index1.47M1.03%-33.65K
International Biotechnology Ord997.22K0.70%-
iShares Biotechnology ETF908.41K0.63%-5.43K
State St Russell Sm/Mid Cp® Indx NL Cl C900.20K0.63%-
iShares Russell 2000 Growth ETF874.88K0.61%-
Nuveen Quant Small Cap Equity R6847.45K0.59%-
GS Glb Sm Cp CORE Eq Base Inc USD Close620.15K0.43%-
Vanguard Russell 2000 ETF613.39K0.43%-3.81K
State St Russell Sm Cap® Indx SL Cl I493.25K0.34%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 11, 2024Bailey Jeffrey Allen-Sell$38.42K
Nov 11, 2024Smith Karen L.-Sell$44.18K
Aug 06, 2024Habig Scott Michael Chief Commercial OfficerSell$96.90K
May 21, 2024Balakrishnan Brinda-Sell$2.98K
May 21, 2024Billen Daniel-Sell$30.15K

Insider Transactions Trends

DateBuySell
2024 Q4-2
2024 Q3-1
2024 Q2-5
2024 Q1-8
2023 Q3--

AUPH Ownership FAQ

Who Owns Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals shareholders are primarily institutional investors at 38.41%, followed by 7.06% insiders and 54.53% retail investors. The average institutional ownership in Aurinia Pharmaceuticals's industry, Biotech Stocks , is 44.97%, which Aurinia Pharmaceuticals falls below.

Who owns the most shares of Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals’s largest shareholders are Armistice capital (11.14M shares, 7.73%), Blackrock (9.27M shares, 6.44%), and Nea management company (3.97M shares, 2.76%). Together, they hold 16.93% of Aurinia Pharmaceuticals’s total shares outstanding.

Does Blackrock own Aurinia Pharmaceuticals?

Yes, BlackRock owns 6.44% of Aurinia Pharmaceuticals, totaling 9.27M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 52.94M$. In the last quarter, BlackRock increased its holdings by 609.18K shares, a 7.03% change.

Who is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Nea management company is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.71% of its assets in 3.97M Aurinia Pharmaceuticals shares, valued at 22.67M$.

Who is the top mutual fund holder of Aurinia Pharmaceuticals shares?

iShares Russell 2000 ETF is the top mutual fund holder of Aurinia Pharmaceuticals shares, with 2.40% of its total shares outstanding invested in 3.44M Aurinia Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools